Table 3.
Health Status and activity by NT-proBNP quartiles
| Quartile 1 (n = 174) | Quartile 2 (n = 171) | Quartile 3 (n = 172) | Quartile 4 (n = 168) | p-value | |
|---|---|---|---|---|---|
| NT-proBNP range, ng/L | 5–35 | 36–71 | 72–135 | 136–4284 | |
| KCCQ physical limitation score, mean ± SD | 92 (15) | 89 (16) | 89 (16) | 86 (19) | 0.016 |
| KCCQ clinical summary score, mean ± SD | 93 (11) | 90 (15) | 90 (15) | 88 (15) | 0.014 |
| KCCQ overall summary score, mean ± SD | 92 (12) | 90 (15) | 90 (15) | 88 (16) | 0.10 |
| PASE score, mean ± SD | 163 (95) | 169 (100) | 152 (79) | 135 (82) | 0.008 |
NT-proBNP, N-terminal pro-B-type natriuretic peptide; E/e’, Ratio between early mitral inflow velocity and mitral annular early diastolic velocity; GLS, global longitudinal strain; LAVI, Left atrial volume indexed; LVEF, left ventricular ejection fraction; LVMI, left ventricular mass indexed; RVSP, right ventricular systolic pressure; *≥ 115 g/m2 in men and ≥ 95 g/m2 in women.